Processing

Please wait...

Settings

Settings

Goto Application

1. MXPA/a/2003/000474 - TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II

Office
Mexico
Application Number PA/a/2003/000474
Application Date 17.01.2003
Publication Number PA/a/2003/000474
Publication Date 17.03.2004
Publication Kind A
IPC
A61K 38/46
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
A61K 38/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
47acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A61K 45/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A61P 21/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21Drugs for disorders of the muscular or neuromuscular system
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
Applicants DUKE UNIVERSITY
Inventors CHEN, Yuan-Tsong
Agents RAFAEL BELTRAN RIVERA*
Priority Data 60/219,237 18.07.2000 US
Title
(EN) TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II
(ES) TRATAMIENTO DE ENFERMEDAD POR DEPÓSITO DE GLUCÓNENO, TIPO II
Abstract
(EN) Methods of treating glycogen storage disease type II, by administering acid agr;-glucosidase, are described, as are compositions for use in treatment of glycogen storage disease type II.
(ES) La presente invención se refiere a métodos para el tratamiento de la enfermedad de depósito de glucógeno de tipo II, mediante la administración de alfa-glucosidasaácida, por ser composiciones para uso en el tratamiento del depósito de glucógeno Tipo II.